These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17105662)

  • 21. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Koram KA; Abuaku B; Duah N; Quashie N
    Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
    Tagbor H; Bruce J; Browne E; Randal A; Greenwood B; Chandramohan D
    Lancet; 2006 Oct; 368(9544):1349-56. PubMed ID: 17046467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania.
    Hetzel MW; Dillip A; Lengeler C; Obrist B; Msechu JJ; Makemba AM; Mshana C; Schulze A; Mshinda H
    BMC Public Health; 2008 May; 8():157. PubMed ID: 18471299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria in Mvumi, central Tanzania and the in vivo response of Plasmodium falciparum to chloroquine and sulphadoxine pyrimethamine.
    Wakibara JV; Mboera LE; Ndawi BT
    East Afr Med J; 1997 Feb; 74(2):69-71. PubMed ID: 9185387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
    Mulligan JA; Mandike R; Palmer N; Williams H; Abdulla S; Bloland P; Mills A
    Trop Med Int Health; 2006 Apr; 11(4):452-61. PubMed ID: 16553928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
    Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK
    East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan.
    Salah MT; Mohammed MM; Himeidan YE; Malik EM; Elbashir MI; Adam I
    Saudi Med J; 2005 Jan; 26(1):147-8. PubMed ID: 15756376
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
    Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.
    Mugittu K; Abdulla S; Falk N; Masanja H; Felger I; Mshinda H; Beck HP; Genton B
    Malar J; 2005 Nov; 4():55. PubMed ID: 16297234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy.
    Tarimo DS; Minjas JN; Bygbjerg IC
    Trop Med Int Health; 2001 Dec; 6(12):992-7. PubMed ID: 11737836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan.
    Stivanello E; Cavailler P; Cassano F; Omar SA; Kariuki D; Mwangi J; Piola P; Guthmann JP
    Trop Med Int Health; 2004 Sep; 9(9):975-80. PubMed ID: 15361110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Lemnge MM; Ali AS; Malecela EK; Sambu E; Abdulla R; Juma MS; Fakih K; Abdulla KH; Njau RJ
    Am J Trop Med Hyg; 2005 Oct; 73(4):681-5. PubMed ID: 16222009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Sulphadoxine and Pyrimethamine, Doxycycline and their combination in the treatment of chloroquine resistant Falciparum Malaria.
    Elkheir HK; Elkarim EF; Eltayeb IB; Elkadaru AE; Babiker HA; Ibrahim AM
    Saudi Med J; 2001 Aug; 22(8):690-3. PubMed ID: 11573114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
    Mwendera C; de Jager C; Longwe H; Phiri K; Hongoro C; Mutero CM
    Health Res Policy Syst; 2016 Jun; 14(1):41. PubMed ID: 27246503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
    Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
    Checchi F; Roddy P; Kamara S; Williams A; Morineau G; Wurie AR; Hora B; Lamotte Nd; Baerwaldt T; Heinzelmann A; Danks A; Pinoges L; Oloo A; Durand R; Ranford-Cartwright L; Smet M;
    Trop Med Int Health; 2005 Feb; 10(2):146-53. PubMed ID: 15679557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
    Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
    Malar J; 2007 May; 6():54. PubMed ID: 17477865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.